Form 4 Filing for Evommune, Inc. - Officer Stock Transactions

This Form 4 filing details stock transactions by Patel Jeegar Pravinkumar, Chief Scientific Officer of Evommune, Inc. On June 22, 2026, Mr. Pravinkumar acquired 1,488 shares of Common Stock under a Rule 10b5-1 trading plan at a price of $3.84 per share. Concurrently, he disposed of 1,488 shares of Common Stock at a price of $22.50 per share. The filing also reports the exercise and disposal of 1,488 employee stock options with an exercise price of $3.84, which were granted under a vesting schedule starting on the first anniversary of the grant date and continuing in monthly installments thereafter, subject to continued service. These transactions were executed under a pre-arranged trading plan.